Literature DB >> 14961959

Outcome of the perioperative use of percutaneous cardiopulmonary support for adult cardiac surgery: factors affecting hospital mortality.

Toshifumi Murashita1, Kazuhiro Eya, Tsukasa Miyatake, Yasuhiro Kamikubo, Norihiko Shiiya, Keishu Yasuda, Shigeyuki Sasaki.   

Abstract

Percutaneous cardiopulmonary bypass support (PCPS) has become a widespread standard modality for the treatment of circulatory collapse; however, its clinical use for postcardiotomy low cardiac output syndrome (LOS) has been reported to be unsatisfactory. We reviewed the clinical outcomes of twenty-three patients undergoing cardiac surgery and treated with PCPS. Solitary coronary artery grafting was undertaken for nine patients, while three had concomitant procedures. The remaining patients underwent valvular surgery. The indications for PCPS were preoperative shock in two patients and postcardiotomy LOS or shock in twenty-one patients. All patients except one underwent an intraaortic balloon pump. Sixteen of the twenty-three patients (69.6%) were weaned from PCPS and twelve patients (52.2%) reached hospital discharge. A univariate analysis revealed that risk factors for hospital mortality were age older than seventy years (P = 0.05), PCPS running time (P = 0.017), low cardiac function at the institution of PCPS (P = 0.004), and urine output within the initial 24 h (P = 0.041). The cardiac index (CI) in survivors was improved within 24 h, and eleven of the twelve survivors were weaned off PCPS within 48 h, whereas ten of the twelve nonsurvivors required PCPS for more than 48 h (P = 0.0006). There is little possibility of weaning patients from PCPS who do not show any signs of hemodynamic recovery within 48 h after its institution. Limited use of PCPS within 48 h may be applicable for postcardiotomy patients, but other cardiopulmonary support, such as a left ventricular assist device, may be required when hemodynamic recovery is not obtained within 48 h.

Entities:  

Mesh:

Year:  2004        PMID: 14961959     DOI: 10.1111/j.1525-1594.2003.47255.x

Source DB:  PubMed          Journal:  Artif Organs        ISSN: 0160-564X            Impact factor:   3.094


  6 in total

1.  Short-term Mechanical Circulatory Support with a Centrifugal Pump - Results of Peripheral Extracorporeal Membrane Oxygenator According to Clinical Situation.

Authors:  Woo Surng Lee; Hyun Keun Chee; Meong Gun Song; Yo Han Kim; Je Kyoun Shin; Jun Seok Kim; Song Am Lee; Jae Joon Hwang
Journal:  Korean J Thorac Cardiovasc Surg       Date:  2011-02-12

2.  Implantation of left ventricular assist devices under extracorporeal life support in patients with heparin-induced thrombocytopenia.

Authors:  Julia Hillebrand; Juergen Sindermann; Christoph Schmidt; Rolf Mesters; Sven Martens; Mirela Scherer
Journal:  J Artif Organs       Date:  2015-06-05       Impact factor: 1.731

3.  Circulatory assistance and surgery for residual pulmonary hypertension following thromboendarterectomy.

Authors:  Mitsuru Yamashita; Motomi Ando; Yoshiro Higuchi; Kiyotoshi Akita; Masato Tochii; Michiko Ishida; Kan Kaneko; Masato Sato; Yasushi Takagi
Journal:  Ann Vasc Dis       Date:  2010-03-29

4.  Contemporary Use of Venoarterial Extracorporeal Membrane Oxygenation: Insights from the Multicenter RESCUE Registry.

Authors:  Rahul S Loungani; Marat Fudim; Dave Ranney; Ajar Kochar; Marc D Samsky; Desiree Bonadonna; Akinobu Itoh; Hiroo Takayama; Koji Takeda; Daniel Wojdyla; Adam D DeVore; Mani Daneshmand
Journal:  J Card Fail       Date:  2021-01-13       Impact factor: 5.712

5.  The use of extracorporeal membrane oxygenation in patients with therapy refractory cardiogenic shock as a bridge to implantable left ventricular assist device and perioperative right heart support.

Authors:  Mirela Scherer; Anton Moritz; Sven Martens
Journal:  J Artif Organs       Date:  2009-09-19       Impact factor: 1.731

6.  Results of extracorporeal life support implementation in routine clinical practice: single center experience.

Authors:  Bojan Biočina; Mate Petričević; Dražen Belina; Hrvoje Gašparović; Lucija Svetina; Sanja Konosić; Alexandra White; Višnja Ivančan; Tomislav Kopjar; Davor Miličić
Journal:  Croat Med J       Date:  2014-12       Impact factor: 1.351

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.